Gut microbiota in hepatitis B cirrhosis

VernacularTitle:肠道菌群与乙型肝炎肝硬化
Author: Yannan LI ¹ ; Changzheng LI ²
Author Information

1. Department of Gastroenterology， Training Base for Postgraduate Students， PLA Rocket Force Characteristic Medical Center of Jinzhou Medical University， Beijing 100088， China
2. Department of Gastroenterology， PLA Rocket Force Characteristic Medical Center， Beijing 100088， China
Publication Type:Review
Keywords: Hepatitis B; Liver Cirrhosis; Gastrointestinal Microbiome; RNA， Ribosomal， 16S
From: Journal of Clinical Hepatology 2025;41(3):552-555
CountryChina
Language:Chinese
Abstract: Hepatitis B cirrhosis is the most significant component of liver cirrhosis in China， and there is a significant increase in the mortality rate of patients after progression from hepatitis to liver cirrhosis. A large number of studies have shown that gut microbiota may influence the progression of hepatitis B cirrhosis， including the impact on the regulation of inflammatory response and intestinal immunity， the inhibition of HBV， and the production of ammonia-like substances. This article reviews the research advances in the changes in gut microbiota in hepatitis B cirrhosis patients and explores new ideas for the treatment of hepatitis B cirrhosis by intervening in gut microbiota.